Genetic Diagnosis of Primary Immune Deficiencies

Immunology and Allergy Clinics of North America

Volumn 28, Issue 2, 2008, Pages 387-412

  Morra, Massimo ^a   Geigenmuller, Ute ^a   Curran, John ^a   Rainville, Irene R ^a,b   Brennan, Tim ^a   Curtis, Judd ^a   Reichert, Vienna ^a   Hovhannisyan, Hayk ^a   Majzoub, Joseph ^a   Miller, David T ^a,c  

^a Correlagen Diagnostics Inc ^*  (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DECISION MAKING; DIAGNOSTIC ACCURACY; ELECTROPHORESIS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HEALTH CARE PERSONNEL; HUMAN; IMMUNE DEFICIENCY; INHERITANCE; MISSENSE MUTATION; MOLECULAR GENETICS; NEWBORN SCREENING; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RNA SPLICING; SEVERE COMBINED IMMUNODEFICIENCY;

GENES; GENETIC SCREENING; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MUTATION; SEQUENCE ANALYSIS, DNA;

EID: 42049109458     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2008.01.004     Document Type: Review

References (103)

1. The Genetics and Public Policy Center. Genetic testing practice guidelines: translating genetic discoveries into clinical care. 2006. Available at: www.dnapolicy.org/. Accessed November 2007.
2. Genetests: medical genetics information resource [online database]. Seattle (WA): University of Washington; 1993-2007. Available at: www.genetest.org. Accessed November 2007.
3. Burke W. Genetic testing in primary care. Annu Rev Genomics Hum Genet 5 (2004) 1-14
4. Lindegren M.L., Kobrynski L., Rasmussen S.A., et al. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep 53 RR-1 (2004) 1-29
5. Bruton O.C. Agammaglobulinemia. Pediatrics 9 6 (1952) 722-728
6. Buckley R.H. Primary immunodeficiency diseases: dissectors of the immune system. Immunol Rev 185 (2002) 206-219
7. Shearer W.T., Cunningham-Rundles C., and Ochs H.D. Primary immunodeficiency: looking backwards, looking forwards. J Allergy Clin Immunol 113 4 (2004) 607-609
8. Buckley R.H. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 343 18 (2000) 1313-1324
9. Conley M.E. Genetics of primary immunodeficiency diseases. Rev Immunogenet 2 2 (2000) 231-242
10. Lawrence T., Puel A., Reichenbach J., et al. Autosomal-dominant primary immunodeficiencies. Curr Opin Hematol 12 1 (2005) 22-30
11. Bonilla F.A., and Geha R.S. 2. Update on primary immunodeficiency diseases. J Allergy Clin Immunol 117 2 Suppl Mini-Primer (2006) S435-S441
12. Notarangelo L.D., Giliani S., Mazzolari E., et al. Primary immune deficiencies unravel the molecular basis of immune response. Rev Clin Exp Hematol 7 1 (2003) 84-111
13. de Villartay J.P., Fischer A., and Durandy A. The mechanisms of immune diversification and their disorders. Nat Rev Immunol 3 12 (2003) 962-972
14. Cooper M.D., Lanier L.L., Conley M.E., et al. Immunodeficiency disorders. Hematology Am Soc Hematol Educ Program 1 (2003) 314-330
15. Buckley R.H. Primary cellular immunodeficiencies. J Allergy Clin Immunol 109 5 (2002) 747-757
16. Etzioni A., and Ochs H.D. The hyper IgM syndrome-an evolving story. Pediatr Res 56 4 (2004) 519-525
17. Casanova J.L., and Abel L. Primary immunodeficiencies: a field in its infancy. Science 317 5838 (2007) 617-619
18. Marodi L., and Notarangelo L.D. Immunological and genetic bases of new primary immunodeficiencies. Nat Rev Immunol 7 11 (2007) 851-861
19. Boyle J.M., and Buckley R.H. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol 27 5 (2007) 497-502
20. Puck J.M. Population-based newborn screening for severe combined immunodeficiency: steps toward implementation. J Allergy Clin Immunol 120 4 (2007) 760-768
21. Casanova J.L., Fieschi C., Bustamante J., et al. From idiopathic infectious diseases to novel primary immunodeficiencies. J Allergy Clin Immunol 116 2 (2005) 426-430
22. Cotton R.G., Auerbach A.D., Brown A.F., et al. A structured simple form for ordering genetic tests is needed to ensure coupling of clinical detail (phenotype) with DNA variants (genotype) to ensure utility in publication and databases. Hum Mutat 28 10 (2007) 931-932
23. Cotton R.G., Appelbe W., Auerbach A.D., et al. Recommendations of the 2006 Human Variome Project meeting. Nat Genet 39 4 (2007) 433-436
24. Bonilla F.A., Bernstein I.L., Khan D.A., et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94 5 Suppl 1 (2005) S1-S63
25. Lim M.S., and Elenitoba-Johnson K.S. The molecular pathology of primary immunodeficiencies. J Mol Diagn 6 2 (2004) 59-83
26. de Vries E. Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clin Exp Immunol 145 2 (2006) 204-214
27. Cunningham Rundles C., Fleisher T., Markert M.L., et al. New developments in primary immunodeficiencies: report on the 2006 CIS Primary Immunodeficiency Diseases Consortium Conference, June 1, 2006. Clin Immunol 121 3 (2006) 369-371
28. Geha R.S., Notarangelo L.D., Casanova J.L., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 120 4 (2007) 776-794
29. Buckley R.H. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22 (2004) 625-655
30. Buckley R.H. Variable phenotypic expression of mutations in genes of the immune system. J Clin Invest 15 11 (2005) 2974-2976
31. Muller S.M., Ege M., Pottharst A., et al. Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood 98 6 (2001) 1847-1851
32. Aureli A., Piancatelli D., Monaco P.I., et al. Chimerism in a child with severe combined immunodeficiency: a case report. Pediatr Transplant 10 6 (2006) 744-746
33. Hershfield M.S. Genotype is an important determinant of phenotype in adenosine deaminase deficiency. Curr Opin Immunol 15 5 (2003) 571-577
34. Sanger F., Nicklen S., and Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74 12 (1977) 5463-5467
35. Costabile M., Quach A., and Ferrante A. Molecular approaches in the diagnosis of primary immunodeficiency diseases. Hum Mutat 27 12 (2006) 1163-1173
36. Sakharkar M.K., Chow V.T., and Kangueane P. Distributions of exons and introns in the human genome. In Silico Biol 4 4 (2004) 387-393
37. Ronaghi M., Karamohamed S., Pettersson B., et al. Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 242 1 (1996) 84-89
38. Drmanac R., Drmanac S., Strezoska Z., et al. DNA sequence determination by hybridization: a strategy for efficient large-scale sequencing. Science 260 5114 (1993) 1649-1652
39. Chee M., Yang R., Hubbell E., et al. Accessing genetic information with high-density DNA arrays. Science 274 5287 (1996) 610-614
40. Shendure J., Porreca G.J., Reppas N.B., et al. Accurate multiplex polony sequencing of an evolved bacterial genome. Science 309 5741 (2005) 1728-1732
41. Bennett S. Solexa Ltd. Pharmacogenomics 5 4 (2004) 433-438
42. Lee C., Iafrate A.J., and Brothman A.R. Copy number variations and clinical cytogenetic diagnosis of constitutional disorders. Nat Genet 39 7 Suppl (2007) S48-S54
43. Hahn S., Garvin A.M., Di Naro E., et al. Allele drop-out can occur in alleles differing by a single nucleotide and is not alleviated by preamplification or minor template increments. Genet Test 2 4 (1998) 351-355
44. Strachan T., and Read A. Human molecular genetics. 3rd edition (2006), Taylor & Francis Group, London
45. Hirschhorn R., Yang D.R., Puck J.M., et al. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet 13 3 (1996) 290-295
46. Ariga T., Oda N., Yamaguchi K., et al. T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation. Blood 97 9 (2001) 2896-2899
47. Arredondo-Vega F.X., Santisteban I., Richard E., et al. Adenosine deaminase deficiency with mosaicism for a "second-site suppressor" of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy. Blood 99 3 (2002) 1005-1013
48. Strom C.M. Mutation detection, interpretation, and applications in the clinical laboratory setting. Mutat Res 573 1-2 (2005) 160-167
49. den Dunnen J.T., and Antonarakis S.E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15 1 (2000) 7-12
50. Thompson D., Easton D.F., and Goldgar D.E. A full-likelihood method for the evaluation of causality of sequence variants from family data. Am J Hum Genet 73 3 (2003) 652-655
51. Mitchell A.A., Chakravarti A., and Cutler D.J. On the probability that a novel variant is a disease-causing mutation. Genome Res 15 7 (2005) 960-966
52. Petersen G.M., Parmigiani G., and Thomas D. Missense mutations in disease genes: a Bayesian approach to evaluate causality. Am J Hum Genet 62 6 (1998) 1516-1524
53. Judkins T., Hendrickson B.C., Deffenbaugh A.M., et al. Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1. Mutat Res 573 1-2 (2005) 168-179
54. McKusick V.A. Mendelian inheritance in man. A catalog of human genes and genetic disorders. 1st edition (1966), Johns Hopkins University Press, Baltimore (MD)
55. Vihinen M., Arredondo-Vega F.X., Casanova J.L., et al. Primary immunodeficiency mutation databases. Adv Genet 43 (2001) 103-188
56. Piirila H., Valiaho J., and Vihinen M. Immunodeficiency mutation databases (IDbases). Hum Mutat 27 12 (2006) 1200-1208
57. Patrinos G.P., and Brookes A.J. DNA, diseases and databases: disastrously deficient. Trends Genet 21 6 (2005) 333-338
58. Wheeler D.L., Barrett T., Benson D.A., et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 35 Database issue (2007) D5-D12
59. The International HapMap Consortium. The International HapMap project. Nature 426 6968 (2003) 789-796
60. Fredman D., Munns G., Rios D., et al. HGVbase: a curated resource describing human DNA variation and phenotype relationships. Nucleic Acids Res 32 Database issue (2004) D516-D519
61. Cartegni L., Wang J., Zhu Z., et al. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31 13 (2003) 3568-3571
62. Pertea M., Lin X., and Salzberg S.L. GeneSplicer: a new computational method for splice site prediction. Nucleic Acids Res 29 5 (2001) 1185-1190
63. Dogan R.I., Getoor L., Wilbur W.J., et al. SplicePort-an interactive splice-site analysis tool. Nucleic Acids Res 35 Web Server issue (2007) W285-W291
64. Butte M.J., Haines C., Bonilla F.A., et al. IL-7 receptor deficient SCID with a unique intronic mutation and post-transplant autoimmunity due to chronic GVHD. Clin Immunol 125 2 (2007) 159-164
65. Ng P.C., and Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 7 (2006) 61-80
66. Henikoff S., and Henikoff J.G. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A 89 22 (1992) 10915-10919
67. Grantham R. Amino acid difference formula to help explain protein evolution. Science 185 4154 (1974) 862-864
68. Riva A., and Kohane I.S. SNPper: retrieval and analysis of human SNPs. Bioinformatics 18 12 (2002) 1681-1685
69. Ng P.C., and Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31 13 (2003) 3812-3814
70. Ramensky V., Bork P., and Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30 17 (2002) 3894-3900
71. Ng P.C., and Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res 12 3 (2002) 436-446
72. Abkevich V., Zharkikh A., Deffenbaugh A.M., et al. Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet 41 7 (2004) 492-507
73. Kondrashov A.S., Sunyaev S., and Kondrashov F.A. Dobzhansky-Muller incompatibilities in protein evolution. Proc Natl Acad Sci U S A 99 23 (2002) 14878-14883
74. Birney E., Stamatoyannopoulos J.A., Dutta A., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447 7146 (2007) 799-816
75. Chan P.A., Duraisamy S., Miller P.J., et al. Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR). Hum Mutat 28 7 (2007) 683-693
76. Roos D., de Boer M., Kuribayashi F., et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 87 5 (1996) 1663-1681
77. Lee W.I., Torgerson T.R., Schumacher M.J., et al. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 105 5 (2005) 1881-1890
78. Conley M.E., and Rohrer J. The spectrum of mutations in Btk that cause X-linked agammaglobulinemia. Clin Immunol Immunopathol 76 3 Pt 2 (1995) S192-S197
79. Tabata Y., Villanueva J., Lee S.M., et al. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood 105 8 (2005) 3066-3071
80. Deering R.P., and Orange J.S. Development of a clinical assay to evaluate toll-like receptor function. Clin Vaccine Immunol 13 1 (2006) 68-76
81. Morra M., Howie D., Grande M.S., et al. X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu Rev Immunol 19 (2001) 657-682
82. Morra M., Silander O., Calpe S., et al. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. Blood 98 5 (2001) 1321-1325
83. Morra M., Simarro-Grande M., Martin M., et al. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients. J Biol Chem 276 39 (2001) 36809-36816
84. Kazazian H.H., Boehm C.D., and Seltzer W.K. ACMG recommendations for standards for interpretation of sequence variations. ACMG Laboratory Practice Committee Working Group. Genet Med 2 5 (2000) 302-303
85. Notarangelo L.D., Lanzi G., Peron S., et al. Defects of class-switch recombination. J Allergy Clin Immunol 117 4 (2006) 855-864
86. Rigaud S., Fondaneche M.C., Lambert N., et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444 7115 (2006) 110-114
87. Vihinen M., and Durandy A. Primary immunodeficiencies: genotype-phenotype correlations. In: Falus A. (Ed). Immunogenomics and human disease (2006), John Wiley & Sons, Ltd, Hoboken (NJ) 443-460
88. Conley M.E., Broides A., Hernandez-Trujillo V., et al. Genetic analysis of patients with defects in early B-cell development. Immunol Rev 203 (2005) 216-234
89. Garibyan L., Lobito A.A., Siegel R.M., et al. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). J Clin Invest 117 6 (2007) 1550-1557
90. Castigli E., Wilson S., Garibyan L., et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 39 4 (2007) 430-431
91. Pan-Hammarstrom Q., Salzer U., Du L., et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 39 4 (2007) 429-430
92. Fudenberg H.H., Good R.A., Hitzig W., et al. Classification of the primary immune deficiencies: WHO recommendation. N Engl J Med 283 12 (1970) 656-657
93. Fudenberg H., Good R.A., Goodman H.C., et al. Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics 47 5 (1971) 927-946
94. Notarangelo L., Casanova J.L., Conley M.E., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 117 4 (2006) 883-896
95. Seemayer T.A., Gross T.G., Egeler R.M., et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 38 4 (1995) 471-478
96. Howie D., Laroux F.S., Morra M., et al. Cutting edge: the SLAM family receptor Ly108 controls T cell and neutrophil functions. J Immunol 174 10 (2005) 5931-5935
97. Hron J.D., Caplan L., Gerth A.J., et al. SH2D1A regulates T-dependent humoral autoimmunity. J Exp Med 200 2 (2004) 261-266
98. Wandstrat A.E., Nguyen C., Limaye N., et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 21 6 (2004) 769-780
99. Engel P., Eck M.J., and Terhorst C. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat Rev Immunol 3 10 (2003) 813-821
100. Morra M., Barrington R.A., Abadia-Molina A.C., et al. Defective B cell responses in the absence of SH2D1A. Proc Natl Acad Sci U S A 102 13 (2005) 4819-4823
101. Crotty S., Kersh E.N., Cannons J., et al. SAP is required for generating long-term humoral immunity. Nature 421 6920 (2003) 282-287
102. Morra M., Lu J., Poy F., et al. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells. EMBO J 20 21 (2001) 5840-5852
103. Roncagalli R., Taylor J.E., Zhang S., et al. Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor. Nat Immunol 6 10 (2005) 1002-1010